The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi Sankyo; Eisai
Speakers' Bureau - Bayer
Research Funding - Bayer (Inst); Daiichi Sankyo/Lilly (Inst); Guardant Health (Inst); Roche/Genentech (Inst)
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Lilly; Merck; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PAREXEL International Inc. (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst)
 
Rosine Guimbaud
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Pierre Fabre
Speakers' Bureau - Amgen; AstraZeneca/MedImmune; SERVIER
Travel, Accommodations, Expenses - BMS
 
Ian Chau
Honoraria - Eisai; Lilly; SERVIER
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; OncXerna Therapeutics; Pierre Fabre; Roche/Genentech; Sotio
Research Funding - Janssen-Cilag (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD
 
Marc Van Den Eynde
Consulting or Advisory Role - amgen (Inst); Lilly (Inst); Merck KGaA (Inst); SERVIER (Inst)
Research Funding - Merck KGaA (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); Roche (Inst)
 
Joan Maurel
Consulting or Advisory Role - Advance Medical; AstraZeneca; Bayer; Cancer Expert Now; Fundación Clínica Universitaria; Pierre Fabre; Sanofi; SERVIER; Shire; Sirtex Medical
Research Funding - Agency for Management of University and Research Grants (AGAUR); Amgen; Biocartis; Fundació la Marató de TV3 (201330.10); Incyte; Merck; NanoString Technologies; Roche
Patents, Royalties, Other Intellectual Property - EP21382772.8
Travel, Accommodations, Expenses - Amgen
 
Jeanne Tie
Honoraria - Inivata; SERVIER
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Haystack Oncology; Inivata; MSD Oncology; Pierre Fabre
 
Tae Won Kim
Employment - Asan Medical Center
Research Funding - AstraZeneca (Inst); Sanofi (Inst)
 
Kun-Huei Yeh
Honoraria - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Lilly; Merck Serono; Merck Sharp & Dohme; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Merck Sharp & Dohme
 
Daniel Barrios
Employment - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Kojiro Kobayashi
Employment - Daiichi Sankyo
 
Emarjola Bako
Stock and Other Ownership Interests - Alibaba Group (Inst); Apple (Inst); Daiichi Sankyo (Inst); Infosys (Inst)
 
Mehreteab Aregay
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Gerold Meinhardt
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Salvatore Siena
Stock and Other Ownership Interests - Guardant Health; Myriad Genetics
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; CheckmAb; Clovis Oncology; Daiichi Sankyo; Incyte; Merck; Novartis; Roche/Genentech; Seagen
Research Funding - MSD Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Bayer; Roche